secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001829126-25-002326
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Appoints Ron Borsheim as Chief Sales Officer - Aesthetics effective April 1, 2025
--------------------------------------------------------------------------------

- Base salary of $225,000 per year; option to purchase 40,000 shares at $2.50/share.
- Option vests 50% on first anniversary, 50% on second anniversary; five-year term.
- Borsheim has 30+ years experience in aesthetic and regenerative medicine sales, previously at Benev Company, Sofwave Medical, BTL Industries.
- Severance: 1/4 month salary per 3 months completed after 90 days if terminated without cause or for good reason.
- Position reports to CEO; remote work from Jacksonville Beach, FL with travel to headquarters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/0001829126-25-002326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/zeoscientifix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-002326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer